FDA Inspection 756349 — Takeda Pharmaceuticals USA, Inc.
The FDA completed an inspection of Takeda Pharmaceuticals USA, Inc. on December 8, 2011 in Deerfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 8, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Deerfield, IL (United States)
Additional Details
Sponsor, Contract Research Organization